scholarly journals Oral and Pharyngeal Cancer Incidence and Mortality Among Hispanics, 1996–2002: The Need for Ethnoregional Studies in Cancer Research

2006 ◽  
Vol 96 (12) ◽  
pp. 2194-2200 ◽  
Author(s):  
Gustavo D. Cruz ◽  
Christian R. Salazar ◽  
Douglas E. Morse
Keyword(s):  
Cancer Research ◽  
Cancer Incidence ◽  
Pharyngeal Cancer ◽  
Incidence And Mortality ◽  
Oral And Pharyngeal Cancer

Global trends in oral and pharyngeal cancer incidence and mortality

2020 ◽  
Vol 147 (4) ◽  
pp. 1040-1049 ◽  
Author(s):  
Cristina Bosetti ◽  
Greta Carioli ◽  
Claudia Santucci ◽  
Paola Bertuccio ◽  
Silvano Gallus ◽  
...  
Keyword(s):  
Cancer Incidence ◽  
Pharyngeal Cancer ◽  
Global Trends ◽  
Incidence And Mortality ◽  
Oral And Pharyngeal Cancer

scholarly journals Analysis of main statistical indicators of oral and pharyngeal cancer in the Republic of Uzbekistan

2021 ◽  
Vol 62 (4) ◽  
pp. 4-8
Author(s):  
J. Alimov ◽  
N. Karimova
Keyword(s):  
Oral Cavity ◽  
Cancer Incidence ◽  
Economic Losses ◽  
Malignant Neoplasms ◽  
Pharyngeal Cancer ◽  
Incidence And Mortality ◽  
Oral And Pharyngeal Cancer ◽  
The Republic ◽  
Statistical Indicators ◽  
Late Detection

Relevance: According to GLOBOCAN data for 2020, oral and pharyngeal cancer ranked 25th in mortality (98 412 cases, 0.5% of all cancer deaths) and 26th in the number of diagnosed new cases (48 143 cases, 0.5% of all new cancer cases) in the world. Oral and pharyngeal cancer incidence is growing steadily globally and in the Republic of Uzbekistan. Oral and pharyngeal cancer ranks 16th in the structure of cancer incidence in the Republic of Uzbekistan, with a rate of 1.8 per 100 000 people. The purpose of the study was to analyze the main statistical indicators for tumors of the oral cavity and pharynx in the Republic of Uzbekistan in 2015-2021. Methods: We analyzed the main statistical indicators for tumors of the oral cavity and pharynx in the Republic of Uzbekistan for 2015- 2020 obtained from the Reporting Form #7 “Information about malignant neoplasms cases.” Results: Over the past six years, the incidence rate per 100,000 people has increased from 1.4 in 2015 to 1.8 in 2020. In 2015-2020, in the Republic of Uzbekistan, 2,240 patients died from malignant neoplasms of the oral cavity and pharynx. The mortality rate per 100,000 people decreased from 1.4 in 2015 to 1.2 in 2020. Conclusions: Tumors of the oral cavity and pharynx rank 16th in the structure of cancer incidence in the Republic of Uzbekistan and tend to grow. A recent increase in oral and pharyngeal cancer incidence and its late detection could be explained by worsening detection and diagnostics. The stabilization of oral and pharyngeal cancer mortality results in socio-economic losses for the Republic. The provided statistical data is the basis for improving the indicators of incidence and mortality related to oral and pharyngeal cancer in the Republic of Uzbekistan

scholarly journals The Epidemiological Trend of Oral Carcinoma in Eastern Europe

2019 ◽  
Vol 70 (8) ◽  
pp. 2917-2922
Author(s):  
Ramona Camelia Rumel ◽  
Laura Cristina Rusu ◽  
Pusa Nela Gaje ◽  
Ramona Amina Popovici ◽  
Marius Raica
Keyword(s):  
Oral Cancer ◽  
World Health ◽  
Pharyngeal Cancer ◽  
East Europe ◽  
Epidemiological Trend ◽  
Incidence And Mortality ◽  
Oral And Pharyngeal Cancer ◽  
Specific Mortality ◽  
Health Organization ◽  
Very High

Oral and pharyngeal cancer is estimated by World Health Organization (WHO) to be the eighth most common cancer worldwide with signi�cant regional variation with increasing and decreasing incidence trend. The aim of the study was to evaluate the oral cancer epidemiological trend, incidence and mortality in Central and East Europe (CEE), and to compare the incidence of oral cancer with other regions from the world. The analyzed data was from NORDCAN and GLOBOCAN, using ASR (age- standardize rate) incidence and mortality overall and by sexes. The incidence of oral and pharyngeal cancer is higher in CEE than the global incidence. This is in accord with specific mortality from oral and pharyngeal cancer that is higher in CEE than the regions other submitted to the current evaluation. The incidence of oral cancer is very high at man, especially in Hungary, which is the most affected from oral cancer from CEE.

scholarly journals Analysis of the National Cancer Institute’s Investment in Site-Specific Cancer Research Funding Involving Collaborators in Latin America and Its Correspondence to Regional Cancer Burden

2020 ◽  
Vol 6 (Supplement_1) ◽  
pp. 21-21
Author(s):  
Jasmin Serena Vargas ◽  
Rachel Abudu ◽  
Kalina Duncan
Keyword(s):  
Cancer Research ◽  
Latin America ◽  
Cancer Incidence ◽  
National Cancer Institute ◽  
Research Funding ◽  
Tumor Site ◽  
Site Specific ◽  
Cancer Burden ◽  
Incidence And Mortality ◽  
Uterine Cancers

PURPOSE Economic and social-behavioral changes over the last two decades in Latin America and the Caribbean (LAC) are associated with increases in the regional cancer burden. We aim to describe the National Cancer Institute–funded extramural research portfolio with collaborators in the LAC between fiscal years 2014 and 2018 and compare project numbers by site with subregional cancer burden. METHODS This analysis included National Cancer Institute–funded extramural projects with LAC collaborators from fiscal years 2014 to 2018 from the National Institutes of Health IMPAC II database. Projects were stratified by Pan American Health Organization’s Latin American subregions, tumor sites, and regional site-specific rates of cancer incidence and mortality using Globocan 2018 estimates. To better understand subregional variations in cancer incidence and mortality, this analysis focused on the top 5 sites of incidence and mortality in LAC after breast and prostate cancer. RESULTS Between fiscal years 2014 and 2018, 108 projects with LAC collaborators were funded. Project collaborators came from 22 countries in the region, and projects covered 20 tumor sites. The Southern Cone had the most projects funded, followed by the Central American Isthmus and Mexico, Andes, Latin Caribbean, and non-Latin Caribbean—this was roughly proportional to subregional populations. Variation exists at the subregional level for the top 5 cancers when comparing incidence and mortality with subregional project counts. Disparities between projects and incidence by tumor site were the largest for colorectal, lung, and uterine cancers. Disparities between projects and mortality by tumor site were the largest for lung and uterine cancers. Disparities between projects and both components of cancer burden by subregion were the largest for the Latin Caribbean and non-Latin Caribbean. The number of funded projects for Kaposi sarcoma and non-Hodgkin lymphoma largely outpaced both incidence and mortality in every subregion. CONCLUSION This analysis suggests that projects’ alignment with cancer burden is variable by subregion, provides an understanding of cancer research funding by site, and highlights areas of interest for additional investigation, training, and collaboration in LAC.

Sign in / Sign up

Export Citation Format

Share Document